Item Type | Name |
Concept
|
Gastroenterology
|
Academic Article
|
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
|
Academic Article
|
Protection from primary sclerosing cholangitis: smoke trails of just coattails?
|
Academic Article
|
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.
|
Academic Article
|
Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591.
|
Academic Article
|
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
|
Academic Article
|
Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease.
|
Academic Article
|
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.
|
Academic Article
|
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.
|
Academic Article
|
Primary sclerosing cholangitis and ulcerative colitis: potential cofactors in the dysplasia sequence.
|
Academic Article
|
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.
|
Academic Article
|
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity.
|
Academic Article
|
American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12.
|
Academic Article
|
Sulfasalazine vs. steroids in Crohn's disease: David vs. Goliath?
|
Academic Article
|
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Surveying surveillance: are gastroenterologists consistently inconsistent, inconsistently consistent, or poorly educated?
|
Academic Article
|
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
|
Academic Article
|
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.
|
Academic Article
|
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.
|
Academic Article
|
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.
|
Academic Article
|
AGA technical review on perianal Crohn's disease.
|
Academic Article
|
Considerations in the management of steroid-dependent Crohn's disease.
|
Academic Article
|
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.
|
Academic Article
|
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
|
Academic Article
|
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
|
Academic Article
|
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
|
Academic Article
|
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis.
|
Academic Article
|
Subgroups.
|
Academic Article
|
A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
|
Academic Article
|
The absence of an association between oral contraceptive use and ulcerative colitis in patients.
|
Academic Article
|
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
|
Academic Article
|
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.
|
Academic Article
|
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.
|
Academic Article
|
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
|
Academic Article
|
Abatacept for Crohn's disease and ulcerative colitis.
|
Academic Article
|
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
|
Academic Article
|
Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn's disease.
|
Academic Article
|
Treatment of Crohn's disease: the "long" of it.
|
Academic Article
|
Circulating lymphocyte subpopulations in Crohn's disease.
|
Academic Article
|
Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
|
Academic Article
|
Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study.
|
Academic Article
|
Association between higher predicted serum vitamin D levels and reduced incidence of inflammatory bowel diseases.
|
Academic Article
|
Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease.
|
Academic Article
|
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
|
Academic Article
|
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
|
Academic Article
|
Prevalence and incidence of inflammatory bowel disease in family members.
|
Academic Article
|
Lack of association between oral contraceptive use and ulcerative colitis.
|
Academic Article
|
A poor view from specialty silos.
|
Academic Article
|
Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study.
|
Academic Article
|
Effect of disodium azodisalicylate on electrolyte transport in rabbit ileum and colon in vitro. Comparison with sulfasalazine and 5-aminosalicylic acid.
|
Academic Article
|
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
|
Academic Article
|
Medical therapy for ulcerative colitis 2004.
|
Academic Article
|
Another one bites the dust.
|
Academic Article
|
Infliximab or cyclosporine for severe ulcerative colitis.
|
Academic Article
|
Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
|
Academic Article
|
The Holy Grail, or only half way there?
|
Academic Article
|
ACG presidential introduction.
|
Academic Article
|
Still in pursuit.
|
Academic Article
|
American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
|
Academic Article
|
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
|
Academic Article
|
Radiation exposure in gastroenterology: improving patient and staff protection.
|
Academic Article
|
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
|
Academic Article
|
Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
|
Academic Article
|
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
|
Academic Article
|
Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
|
Academic Article
|
The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications.
|
Academic Article
|
Executive Summary of 'Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States'.
|
Academic Article
|
Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States.
|
Academic Article
|
Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer.
|
Academic Article
|
Which Diet for Crohn's Disease? Food for Thought on the Specific Carbohydrate Diet, Mediterranean Diet, and Beyond.
|
Academic Article
|
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
|
Academic Article
|
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
|
Academic Article
|
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).
|